IDEAYA Biosciences, Inc. Cash Flow Statement

Cash Flow Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -44.27M-35.34M-50.27M-62.50M-134.43M-326.98M
Share-based Compensation 0.14M0.95M2.17M3.61M8.24M11.63M18.49M34.75M
Gains from Sales and Divestitures 0.00M0.01M
Gains from Investment Securities 0.05M0.67M1.19M0.00M1.80M16.90M32.00M
Non-cash Items 5.90M0.02M0.04M28.00M41.10M90.20M
Cash from Operations -12.22M-27.62M-39.31M55.46M-55.78M-87.17M-115.22M-247.58M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.03M0.81M0.47M-0.58M-1.83M1.41M11.55M23.23M
Depreciation & Amortization (CF) 0.39M0.89M1.25M1.38M1.73M2.10M2.48M2.39M
Change in Working Capital
Change in Receivables 1.88M-0.77M-0.89M-0.19M-0.01M
Change in Account Payables 0.25M0.32M-0.20M0.23M1.17M1.86M2.63M8.28M
Change in Accured Expenses 1.01M1.67M2.03M2.99M4.21M4.57M1.64M10.79M
Other Working Capital Changes -0.33M0.24M1.96M83.77M-23.54M-46.48M-13.75M6.17M
Investing Activities
Capital Expenditures 1.76M1.71M1.35M0.52M2.64M3.44M2.37M3.86M
Change in Acquisitions & Divestments 243.96M225.85M439.89M692.61M
Cash from Investing Activities -8.93M-63.18M2.27M-146.24M-69.67M-33.40M-158.46M-502.56M
Financing Activities
Other financing activities 0.07M
Cash from Financing Activities 17.49M105.38M50.61M128.75M145.45M97.17M362.72M677.55M
Additional items
Change in Cash -3.66M14.58M13.56M37.97M20.01M-23.41M89.04M-72.59M
Free Cash Flow -13.98M-29.33M-40.67M54.94M-58.42M-90.62M-117.59M-251.44M
Net Cash Flow -3.66M14.58M13.56M37.97M20.01M-23.41M89.04M-72.59M